Epstein–Barr and other viral mimicry of autoantigens, myelin and vitamin D-related proteins and of EIF2B, the cause of vanishing white matter disease: massive mimicry of multiple sclerosis relevant proteins by the Synechococcus phage

References

• Quintana, F.J., Farez, M.F., Viglietta, V., Iglesias, A.H., Merbl, Y., Izquierdo, G., Lucas, M., Basso, A.S., Khoury, S.J., Lucchinetti, C.F., Cohen, I.R., Weiner, H.L. Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc Natl Acad Sci USA 2008, 105, 18889–18894.
   PubMed Web of Science ®Google Scholar
• Wekerle, H., Kojima, K., Lannes-Vieira, J., Lassmann, H., Linington, C. Animal models. Ann Neurol 1994, 36, S47–S53.
   PubMed Web of Science ®Google Scholar
• Ascherio, A., Munger, K.L. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: Epstein–Barr virus and multiple sclerosis: epidemiological evidence. Clin Exp Immunol 2010, 160, 120–124.
   PubMed Web of Science ®Google Scholar
• Westall, F.C. Molecular mimicry revisited: gut bacteria and multiple sclerosis. J Clin Microbiol 2006, 44, 2099–2104.
   PubMed Web of Science ®Google Scholar
• Harkiolaki, M., Holmes, S.L., Svendsen, P., Gregersen, J.W., Jensen, L.T., McMahon, R., Friese, M.A., van Boxel, G., Etzensperger, R., Tzartos, J.S., Kranc, K., Sainsbury, S., Harlos, K., Mellins, E.D., Palace, J., Esiri, M.M., van der Merwe, P.A., Jones, E.Y., Fugger, L. T cell-mediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides. Immunity 2009, 30, 348–357.
   PubMed Web of Science ®Google Scholar
• Birnbaum, G., Kotilinek, L. Heat shock or stress proteins and their role as autoantigens in multiple sclerosis. Ann N Y Acad Sci 1997, 835, 157–167.
   PubMed Web of Science ®Google Scholar
• Katzourakis, A., Gifford, R.J. Endogenous viral elements in animal genomes. PLoS Genet 2010, 6, e1001191.
   Web of Science ®Google Scholar
• Geuking, M.B., Weber, J., Dewannieux, M., Gorelik, E., Heidmann, T., Hengartner, H., Zinkernagel, R.M., Hangartner, L. Recombination of retrotransposon and exogenous RNA virus results in nonretroviral cDNA integration. Science 2009, 323, 393–396.
   Google Scholar
• Liu, H., Fu, Y., Jiang, D., Li, G., Xie, J., Cheng, J., Peng, Y., Ghabrial, S.A., Yi, X. Widespread horizontal gene transfer from double-stranded RNA viruses to eukaryotic nuclear genomes. J Virol 2010, 84, 11876–11887.
   PubMed Web of Science ®Google Scholar
• Kanduc, D. Describing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomes. Biologics 2010, 4, 245–261.
   PubMedGoogle Scholar
• Ricco, R., Kanduc, D. Hepatitis B virus and Homo sapiens proteome-wide analysis: A profusion of viral peptide overlaps in neuron-specific human proteins. Biologics 2010, 4, 75–81.
   PubMedGoogle Scholar
• Kanduc, D., Stufano, A., Lucchese, G., Kusalik, A. Massive peptide sharing between viral and human proteomes. Peptides 2008, 29, 1755–1766.
   PubMed Web of Science ®Google Scholar
• Carter, C.J. Alzheimer’s disease: a pathogenetic autoimmune disorder caused by herpes simplex in a gene-dependent manner. Int J Alzheimers Dis 2010, 2010, 140539.
   PubMedGoogle Scholar
• Trost, B., Lucchese, G., Stufano, A., Bickis, M., Kusalik, A., Kanduc, D. No human protein is exempt from bacterial motifs, not even one. Self Nonself 2011, 1, 1–7.
   Google Scholar
• Chatr-aryamontri, A., Ceol, A., Peluso, D., Nardozza, A., Panni, S., Sacco, F., Tinti, M., Smolyar, A., Castagnoli, L., Vidal, M., Cusick, M.E., Cesareni, G. VirusMINT: a viral protein interaction database. Nucleic Acids Res 2009, 37, D669–D673.
   PubMed Web of Science ®Google Scholar
• Navratil, V., de Chassey, B., Combe, C.R., Lotteau, V. When the human viral infectome and diseasome networks collide: towards a systems biology platform for the aetiology of human diseases. BMC Syst Biol 2011, 5, 13.
   Web of Science ®Google Scholar
• Altschul, S.F., Madden, T.L., Schäffer, A.A., Zhang, J., Zhang, Z., Miller, W., Lipman, D.J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997, 25, 3389–3402.
   PubMed Web of Science ®Google Scholar
• Larsen, J.E., Lund, O., Nielsen, M. Improved method for predicting linear B-cell epitopes. Immunome Res 2006, 2, 2.
   PubMedGoogle Scholar
• Nielsen, M., Lundegaard, C., Lund, O., Kesmir, C. The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage. Immunogenetics 2005, 57, 33–41.
   PubMed Web of Science ®Google Scholar
• Lill, C.M., McQueen, M.B., Roehr, J.T., Bagade, S., Schjeide, B.M., Zipp, F., Bertram, L. The MSGene Database. Alzheimer Research Forum. http://www.msgene.org/. MsGene 2010.
   Google Scholar
• Hindorff, L.A., Junkins, H.A., Hallm, P.N., Mehtam, J.P., Manolio, T.A. A Catalog of Published Genome-Wide Association Studies. Available at: www.genome.gov/gwastudies.
   Google Scholar
• Brocchieri, L., Karlin, S. Protein length in eukaryotic and prokaryotic proteomes. Nucleic Acids Res 2005, 33, 3390–3400.
   PubMed Web of Science ®Google Scholar
• van der Knaap, M.S., Pronk, J.C., Scheper, G.C. Vanishing white matter disease. Lancet Neurol 2006, 5, 413–423.
   PubMed Web of Science ®Google Scholar
• Kurazono, M., Nakamura, K., Yamada, M., Yonemaru, T., Sakoda, T. Pathology of listerial encephalitis in chickens in Japan. Avian Dis 2003, 47, 1496–1502.
   PubMed Web of Science ®Google Scholar
• Andersen, O., Lygner, P.E., Bergström, T., Andersson, M., Vahlne, A. Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study. J Neurol 1993, 240, 417–422.
   PubMed Web of Science ®Google Scholar
• Vartdal, F., Vandvik, B., Norrby, E. Viral and bacterial antibody responses in multiple sclerosis. Ann Neurol 1980, 8, 248–255.
   PubMed Web of Science ®Google Scholar
• Brinar, V.V., Habek, M. Rare infections mimicking MS. Clin Neurol Neurosurg 2010, 112, 625–628.
   PubMed Web of Science ®Google Scholar
• Dean, G., McDougall, E.I., Elian, M. Multiple sclerosis in research workers studying swayback in lambs: an updated report. J Neurol Neurosurg Psychiatr 1985, 48, 859–865.
   PubMed Web of Science ®Google Scholar
• Cook, S.D., Dowling, P.C. A possible association between house pets and multiple sclerosis. Lancet 1977, 1, 980–982.
   PubMed Web of Science ®Google Scholar
• Malosse, D., Perron, H. Correlation analysis between bovine populations, other farm animals, house pets, and multiple sclerosis prevalence. Neuroepidemiology 1993, 12, 15–27.
   PubMed Web of Science ®Google Scholar
• Colson, P., Richet, H., Desnues, C., Balique, F., Moal, V., Grob, J.J., Berbis, P., Lecoq, H., Harlé, J.R., Berland, Y., Raoult, D. Pepper mild mottle virus, a plant virus associated with specific immune responses, fever, abdominal pains, and pruritus in humans. PLoS ONE 2010, 5, e10041.
   Google Scholar
• Cantorna, M.T. Vitamin D and multiple sclerosis: an update. Nutr Rev 2008, 66, S135–S138.
   PubMed Web of Science ®Google Scholar
• Shah, K.M., Young, L.S. Epstein–Barr virus and carcinogenesis: beyond Burkitt’s lymphoma. Clin Microbiol Infect 2009, 15, 982–988.
   PubMed Web of Science ®Google Scholar
• Beebe, A.M., Cua, D.J., de Waal Malefyt, R. The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev 2002, 13, 403–412.
   PubMed Web of Science ®Google Scholar
• Toussirot, E., Roudier, J. Epstein–Barr virus in autoimmune diseases. Best Pract Res Clin Rheumatol 2008, 22, 883–896.
   PubMed Web of Science ®Google Scholar
• Apostolou, F., Gazi, I.F., Lagos, K., Tellis, C.C., Tselepis, A.D., Liberopoulos, E.N., Elisaf, M. Acute infection with Epstein–Barr virus is associated with atherogenic lipid changes. Atherosclerosis 2010, 212, 607–613.
   PubMed Web of Science ®Google Scholar
• Muntoni, S., Muntoni, S. Gene-nutrient interactions in G6PD-deficient subjects–implications for cardiovascular disease susceptibility. J Nutrigenet Nutrigenomics 2008, 1, 49–54.
   PubMed Web of Science ®Google Scholar
• Choi, I.Y., Lee, S.P., Denney, D., Lynch, S. Lower levels of glutathione in the brains of secondary progressive multiple sclerosis patients measured by 1H magnetic resonance chemical shift imaging at 3 T. Mult Scler 2011, 17, 289–296.
   PubMed Web of Science ®Google Scholar
• Back, S.A., Gan, X., Li, Y., Rosenberg, P.A., Volpe, J.J. Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J Neurosci 1998, 18, 6241–6253.
   PubMed Web of Science ®Google Scholar
• Paintlia, M.K., Paintlia, A.S., Barbosa, E., Singh, I., Singh, A.K. N-acetylcysteine prevents endotoxin-induced degeneration of oligodendrocyte progenitors and hypomyelination in developing rat brain. J Neurosci Res 2004, 78, 347–361.
   PubMed Web of Science ®Google Scholar
• Ram, M., Anaya, J.M., Barzilai, O., Izhaky, D., Porat Katz, B.S., Blank, M., Shoenfeld, Y. The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders. Autoimmun Rev 2008, 7, 621–625.
   PubMed Web of Science ®Google Scholar
• Ozakbas, S., Idiman, E., Yulug, B., Pakoz, B., Bahar, H., Gulay, Z. Development of multiple sclerosis after vaccination against hepatitis B: a study based on human leucocyte antigen haplotypes. Tissue Antigens 2006, 68, 235–238.
   PubMedGoogle Scholar
• Zivadinov, R., Nasuelli, D., Tommasi, M.A., Serafin, M., Bratina, A., Ukmar, M., Pirko, I., Johnson, A.J., Furlan, C., Pozzi-Mucelli, R.S., Monti-Bragadin, L., Grop, A., Zambon, M., Antonello, R.M., Cazzato, G., Zorzon, M. Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients. Neurol Res 2006, 28, 262–269.
   PubMed Web of Science ®Google Scholar
• Sutton, I., Lahoria, R., Tan, I., Clouston, P., Barnett, M. CNS demyelination and quadrivalent HPV vaccination. Mult Scler 2009, 15, 116–119.
   PubMed Web of Science ®Google Scholar
• Zwirglmaier, K., Jardillier, L., Ostrowski, M., Mazard, S., Garczarek, L., Vaulot, D., Not, F., Massana, R., Ulloa, O., Scanlan, D.J. Global phylogeography of marine Synechococcus and Prochlorococcus reveals a distinct partitioning of lineages among oceanic biomes. Environ Microbiol 2008, 10, 147–161.
   PubMed Web of Science ®Google Scholar
• Falkner, G., Wagner, F., Falkner, R. On the relation between phosphate uptake and growth of the cyanobacterium Anacystis nidulans. C R Acad Sci III, Sci Vie 1994, 317, 535–541.
   PubMed Web of Science ®Google Scholar
• Green, L.S., Laudenbach, D.E., Grossman, A.R. A region of a cyanobacterial genome required for sulfate transport. Proc Natl Acad Sci USA 1989, 86, 1949–1953.
   PubMed Web of Science ®Google Scholar
• Romero, J.M., Flores, E., Guerrero, M.G. Inhibition of nitrate utilization by amino acids in intact Anacystis nidulans cells. Arch Microbiol 1985, 142, 1–5.
   PubMed Web of Science ®Google Scholar
• Van Baalen, C. The photooxidation of uric acid by Anacystis nidulans. Plant Physiol 1965, 40, 368–371.
   PubMed Web of Science ®Google Scholar
• Irvine, D.G., Schiefer, H.B., Hader, W.J. Geotoxicology of multiple sclerosis: the Henribourg, Saskatchewan, Cluster Focus. I. The water. Sci Total Environ 1989, 84, 45–59.
   PubMed Web of Science ®Google Scholar
• Lee, L.H., Lui, D., Platner, P.J., Hsu, S.F., Chu, T.C., Gaynor, J.J., Vega, Q.C., Lustigman, B.K. Induction of temperate cyanophage AS-1 by heavy metal–copper. BMC Microbiol 2006, 6, 17.
   PubMed Web of Science ®Google Scholar
• Ivanov, A.I., Fomchenkov, V.M., Khasanova, L.A., Kuramshina, Z.M., Sadikov, M.M. [Influence of heavy metal ions on the electrophysical properties of Anacystis nidulans and Escherichia coli cells]. Mikrobiologiia 1992, 61, 455–463.
   PubMedGoogle Scholar
• Sherman, D.M., Sherman, L.A. Effect of iron deficiency and iron restoration on ultrastructure of Anacystis nidulans. J Bacteriol 1983, 156, 393–401.
   PubMed Web of Science ®Google Scholar
• Häsänen, E., Kinnunen, E., Alhonen, P. Relationships between the prevalence of multiple sclerosis and some physical and chemical properties of soil. Sci Total Environ 1986, 58, 263–272.
   PubMed Web of Science ®Google Scholar
• Ingalls, T.H. Clustering of multiple sclerosis in Galion, Ohio, 1982-1985. Am J Forensic Med Pathol 1989, 10, 213–215.
   PubMed Web of Science ®Google Scholar
• Amla, D.V. Drift in ultraviolet sensitivity and expression of mutations during synchronous growth of cyanobacterium Anacystis nidulans. Mutat Res 1983, 107, 229–238.
   PubMedGoogle Scholar
• Amla, D.V. Photoreactivation of ultraviolet irradiated blue-green alga: Anacystis nidulans and cyanophage AS-1. Arch Virol 1979, 59, 173–179.
   PubMed Web of Science ®Google Scholar
• Lee, H.L., Cohn, G., Cosowsky, L., McGowan, R., Blamire, J. DNA metabolism during infection of Anacystis nidulans by cyanophage AS-1. VII. UV-induced alterations of the AS-1/A. nidulans lytic cycle. Microbios 1985, 43, 277–295.
   PubMedGoogle Scholar
• Beretich, B.D., Beretich, T.M. Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis. Mult Scler 2009, 15, 891–898.
   PubMed Web of Science ®Google Scholar
• Lucas, R.M., Ponsonby, A.L., Dear, K., Valery, P.C., Pender, M.P., Taylor, B.V., Kilpatrick, T.J., Dwyer, T., Coulthard, A., Chapman, C., van der Mei, I., Williams, D., McMichael, A.J. Sun exposure and vitamin D are independent risk factors for CNS demyelination. Neurology 2011, 76, 540–548.
   PubMed Web of Science ®Google Scholar
• Ramagopalan, S.V., Heger, A., Berlanga, A.J., Maugeri, N.J., Lincoln, M.R., Burrell, A., Handunnetthi, L., Handel, A.E., Disanto, G., Orton, S.M., Watson, C.T., Morahan, J.M., Giovannoni, G., Ponting, C.P., Ebers, G.C., Knight, J.C. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res 2010, 20, 1352–1360.
   PubMed Web of Science ®Google Scholar
• Courbebaisse, M., Souberbielle, J.C., Prié, D., Thervet, E. [Non phosphocalcic actions of vitamin D]. Med Sci (Paris) 2010, 26, 417–421.
   PubMed Web of Science ®Google Scholar
• Bains, W. Exposure of the eyes to near-horizon sunshine may be a trigger for multiple sclerosis. Med Hypotheses 2010, 74, 428–432.
   PubMed Web of Science ®Google Scholar
• Meier, D.S., Balashov, K.E., Healy, B., Weiner, H.L., Guttmann, C.R. Seasonal prevalence of MS disease activity. Neurology 2010, 75, 799–806.
   PubMed Web of Science ®Google Scholar
• Salvi, F., Bartolomei, I., Smolensky, M.H., Lorusso, A., Barbarossa, E., Malagoni, A.M., Zamboni, P., Manfredini, R. A seasonal periodicity in relapses of multiple sclerosis? A single-center, population-based, preliminary study conducted in Bologna, Italy. BMC Neurol 2010, 10, 105.
   PubMed Web of Science ®Google Scholar
• Klupka-Saric, I., Galic, M. Epidemiology of multiple sclerosis in western Herzegovina and Herzegovina–Neretva Canton, Bosnia and Herzegovina. Coll Antropol 2010, 34(Suppl 1), 189–193.
   PubMedGoogle Scholar
• Abad, P., Pérez, M., Castro, E., Alarcón, T., Santibáñez, R., Díaz, F. [Prevalence of multiple sclerosis in Ecuador]. Neurologia 2010, 25, 309–313.
   PubMed Web of Science ®Google Scholar
• Fromont, A., Binquet, C., Sauleau, E.A., Fournel, I., Bellisario, A., Adnet, J., Weill, A., Vukusic, S., Confavreux, C., Debouverie, M., Clerc, L., Bonithon-Kopp, C., Moreau, T. Geographic variations of multiple sclerosis in France. Brain 2010, 133, 1889–1899.
   PubMed Web of Science ®Google Scholar
• Materljan, E., Materljan, M., Materljan, B., Vlacic, H., Baricev-Novakovic, Z., Sepcic, J. Multiple sclerosis and cancers in Croatia–a possible protective role of the “Mediterranean diet”. Coll Antropol 2009, 33, 539–545.
   PubMedGoogle Scholar
• Larsen, J.P., Riise, T., Nyland, H., Kvåle, G., Aarli, J.A. Clustering of multiple sclerosis in the county of Hordaland, Western Norway. Acta Neurol Scand 1985, 71, 390–395.
   PubMed Web of Science ®Google Scholar
• Trost, B., Kusalik, A., Lucchese, G., Kanduc, D. Bacterial peptides are intensively present throughout the human proteome. Self Nonself 2010, 1, 71–74.
   PubMedGoogle Scholar
• Wang, H., Munger, K.L., Reindl, M., O’Reilly, E.J., Levin, L.I., Berger, T., Ascherio, A. Myelin oligodendrocyte glycoprotein antibodies and multiple sclerosis in healthy young adults. Neurology 2008, 71, 1142–1146.
   PubMed Web of Science ®Google Scholar
• Lünemann, J.D., Jelcic, I., Roberts, S., Lutterotti, A., Tackenberg, B., Martin, R., Münz, C. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. J Exp Med 2008, 205, 1763–1773.
   PubMed Web of Science ®Google Scholar
• Carter, C.J. Interactions between the products of the herpes simplex genome and Alzheimer’s disease susceptibility genes: relevance to pathological-signalling cascades. Neurochem Int 2008, 52, 920–934.
   PubMed Web of Science ®Google Scholar
• Carter, C.J. Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii. Schizophr Bull 2009, 35, 1163–1182.
   PubMed Web of Science ®Google Scholar
• Mullen, M.M., Haan, K.M., Longnecker, R., Jardetzky, T.S. Structure of the Epstein–Barr virus gp42 protein bound to the MHC class II receptor HLA-DR1. Mol Cell 2002, 9, 375–385.
   PubMed Web of Science ®Google Scholar
• Yenamandra, S.P., Hellman, U., Kempkes, B., Darekar, S.D., Petermann, S., Sculley, T., Klein, G., Kashuba, E. Epstein–Barr virus encoded EBNA-3 binds to vitamin D receptor and blocks activation of its target genes. Cell Mol Life Sci 2010, 67, 4249–4256.
   PubMed Web of Science ®Google Scholar
• Frémeaux-Bacchi, V., Bernard, I., Maillet, F., Mani, J.C., Fontaine, M., Bonnefoy, J.Y., Kazatchkine, M.D., Fischer, E. Human lymphocytes shed a soluble form of CD21 (the C3dg/Epstein–Barr virus receptor, CR2) that binds iC3b and CD23. Eur J Immunol 1996, 26, 1497–1503.
   PubMed Web of Science ®Google Scholar
• Peters, A.L., Stunz, L.L., Meyerholz, D.K., Mohan, C., Bishop, G.A. Latent membrane protein 1, the EBV-encoded oncogenic mimic of CD40, accelerates autoimmunity in B6.Sle1 mice. J Immunol 2010, 185, 4053–4062.
   PubMed Web of Science ®Google Scholar
• Rothenberger, S., Burns, K., Rousseaux, M., Tschopp, J., Bron, C. Ubiquitination of the Epstein–Barr virus-encoded latent membrane protein 1 depends on the integrity of the TRAF binding site. Oncogene 2003, 22, 5614–5618.
   PubMed Web of Science ®Google Scholar
• Wang, Z., Luo, F., Li, L., Yang, L., Hu, D., Ma, X., Lu, Z., Sun, L., Cao, Y. STAT3 activation induced by Epstein–Barr virus latent membrane protein1 causes vascular endothelial growth factor expression and cellular invasiveness via JAK3 And ERK signaling. Eur J Cancer 2010, 46, 2996–3006.
   PubMed Web of Science ®Google Scholar
• Geiger, T.R., Martin, J.M. The Epstein–Barr virus-encoded LMP-1 oncoprotein negatively affects Tyk2 phosphorylation and interferon signaling in human B cells. J Virol 2006, 80, 11638–11650.
   PubMed Web of Science ®Google Scholar
• Ning, S., Huye, L.E., Pagano, J.S. Interferon regulatory factor 5 represses expression of the Epstein–Barr virus oncoprotein LMP1: braking of the IRF7/LMP1 regulatory circuit. J Virol 2005, 79, 11671–11676.
   PubMed Web of Science ®Google Scholar
• Kvansakul, M., Wei, A.H., Fletcher, J.I., Willis, S.N., Chen, L., Roberts, A.W., Huang, D.C., Colman, P.M. Structural basis for apoptosis inhibition by Epstein–Barr virus BHRF1. PLoS Pathog 2010, 6, e1001236.
   PubMed Web of Science ®Google Scholar
• Bristol, J.A., Robinson, A.R., Barlow, E.A., Kenney, S.C. The Epstein–Barr virus BZLF1 protein inhibits tumor necrosis factor receptor 1 expression through effects on cellular C/EBP proteins. J Virol 2010, 84, 12362–12374.
   PubMed Web of Science ®Google Scholar
• Fukuda, M., Kurosaki, H., Sairenji, T. Loss of functional transforming growth factor (TGF)-beta type II receptor results in insensitivity to TGF-beta1-mediated apoptosis and Epstein–Barr virus reactivation. J Med Virol 2006, 78, 1456–1464.
   PubMed Web of Science ®Google Scholar
• Peel, A.L. PKR activation in neurodegenerative disease. J Neuropathol Exp Neurol 2004, 63, 97–105.
   PubMed Web of Science ®Google Scholar
• Wozniak, M.A., Shipley, S.J., Dobson, C.B., Parker, S.P., Scott, F.T., Leedham-Green, M., Breuer, J., Itzhaki, R.F. Does apolipoprotein E determine outcome of infection by varicella zoster virus and by Epstein–Barr virus? Eur J Hum Genet 2007, 15, 672–678.
   PubMed Web of Science ®Google Scholar
• Hughes, L.E., Smith, P.A., Bonell, S., Natt, R.S., Wilson, C., Rashid, T., Amor, S., Thompson, E.J., Croker, J., Ebringer, A. Cross-reactivity between related sequences found in Acinetobacter sp., Pseudomonas aeruginosa, myelin basic protein and myelin oligodendrocyte glycoprotein in multiple sclerosis. J Neuroimmunol 2003, 144, 105–115.
   PubMed Web of Science ®Google Scholar
• Carter, C.J. Alzheimer’s disease plaques and tangles: Cemeteries of a Pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction. Neurochem Int 2011, 58, 301–320.
   PubMed Web of Science ®Google Scholar
• Rivers, T.M., Sprunt, D.H., Berry, G.P. OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS. J Exp Med 1933, 58, 39–53.
   PubMedGoogle Scholar
• Wang, J.H., Pappas, D., De Jager, P.L., Pelletier, D., de Bakker, P.I., Kappos, L., Polman, C.H., Chibnik, L.B., Hafler, D.A., Matthews, P.M., Hauser, S.L., Baranzini, S.E., Oksenberg, J.R.; Australian and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene). Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data. Genome Med 2011, 3, 3.
   PubMed Web of Science ®Google Scholar
• Lettre, G., Rioux, J.D. Autoimmune diseases: insights from genome-wide association studies. Hum Mol Genet 2008, 17, R116–R121.
   PubMed Web of Science ®Google Scholar
• Jonsson, R., Nakken, B., Halse, A.K., Skarstein, K., Brokstad, K., Haga, H.J. [Heredity and immunology in Sjogren’s syndrome]. Tidsskr Nor Laegeforen 2000, 120, 811–814.
   PubMedGoogle Scholar
• Phillips, D., Prentice, L., Upadhyaya, M., Lunt, P., Chamberlain, S., Roberts, D.F., McLachlan, S., Smith, B.R. Autosomal dominant inheritance of autoantibodies to thyroid peroxidase and thyroglobulin–studies in families not selected for autoimmune thyroid disease. J Clin Endocrinol Metab 1991, 72, 973–975.
   PubMed Web of Science ®Google Scholar
• Janeway, C.A., Travers, P., Walport, M., Schlonchik, M.J. The Immune System in Health and Disease. New York: Garland Science, 2011.
   Google Scholar
• Bartsch, S., Montag, D., Schachner, M., Bartsch, U. Increased number of unmyelinated axons in optic nerves of adult mice deficient in the myelin-associated glycoprotein (MAG). Brain Res 1997, 762, 231–234.
   PubMed Web of Science ®Google Scholar
• Martini, R., Mohajeri, M.H., Kasper, S., Giese, K.P., Schachner, M. Mice doubly deficient in the genes for P0 and myelin basic protein show that both proteins contribute to the formation of the major dense line in peripheral nerve myelin. J Neurosci 1995, 15, 4488–4495.
   PubMed Web of Science ®Google Scholar
• Aboul-Enein, F., Rauschka, H., Kornek, B., Stadelmann, C., Stefferl, A., Brück, W., Lucchinetti, C., Schmidbauer, M., Jellinger, K., Lassmann, H. Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases. J Neuropathol Exp Neurol 2003, 62, 25–33.
   PubMed Web of Science ®Google Scholar
• Pardridge, W.M. Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses. Bioconjug Chem 2008, 19, 1327–1338.
   PubMed Web of Science ®Google Scholar
• Mallery, D.L., McEwan, W.A., Bidgood, S.R., Towers, G.J., Johnson, C.M., James, L.C. Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proc Natl Acad Sci USA 2010, 107, 19985–19990.
   PubMed Web of Science ®Google Scholar
• Ulzheimer, J.C., Meuth, S.G., Bittner, S., Kleinschnitz, C., Kieseier, B.C., Wiendl, H. Therapeutic approaches to multiple sclerosis: an update on failed, interrupted, or inconclusive trials of immunomodulatory treatment strategies. BioDrugs 2010, 24, 249–274.
   PubMed Web of Science ®Google Scholar
• Hosokawa, S., Oyamaguchi, A., Yoshida, O. Successful immunoadsorption with membrane plasmapheresis for multiple sclerosis. ASAIO Trans 1989, 35, 576–577.
   PubMedGoogle Scholar
• Cortese, I., Chaudhry, V., So, Y.T., Cantor, F., Cornblath, D.R., Rae-Grant, A. Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2011, 76, 294–300.
   PubMed Web of Science ®Google Scholar
• Moldenhauer, A., Haas, J., Wäscher, C., Derfuss, T., Hoffmann, K.T., Kiesewetter, H., Salama, A. Immunoadsorption patients with multiple sclerosis: an open-label pilot study. Eur J Clin Invest 2005, 35, 523–530.
   PubMed Web of Science ®Google Scholar
• Nomura, K. [Therapeutic apheresis in multiple sclerosis]. Nippon Rinsho 2003, 61, 1388–1395.
   PubMedGoogle Scholar
• de Andrés, C., Anaya, F., Giménez-Roldán, S. [Plasma immunoadsorption treatment of malignant multiple sclerosis with severe and prolonged relapses]. Rev Neurol 2000, 30, 601–605.
   PubMed Web of Science ®Google Scholar
• Palm, M., Behm, E., Schmitt, E., Buddenhagen, F., Hitzschke, B., Kracht, M., Kundt, G., Meyer-Rienecker, H., Klinkmann, H. Immunoadsorption and plasma exchange in multiple sclerosis: complement and plasma protein behaviour. Biomater Artif Cells Immobilization Biotechnol 1991, 19, 283–296.
   PubMed Web of Science ®Google Scholar
• Schneidewind, J.M., Winkler, R., Ramlow, W., Tiess, M., Hertel, U., Sehland, D. Immunoadsorption–a new therapeutic possibility for multiple sclerosis? Transfus Sci 1998, 19, 59–63.
   PubMedGoogle Scholar
• Schweigreiter, R. The natural history of the myelin-derived nerve growth inhibitor Nogo-A. Neuron Glia Biol 2008, 4, 83–89.
   PubMedGoogle Scholar